ADMA BIOLOGICS, INC. | Business Finance | Business Contracts

Form of Warrant to Purchase Common Stock (Filed With SEC on May 2, 2023)

Amendment No. 2 to the Credit and Guaranty Agreement, dated as of May 1, 2023 (Filed With SEC on May 2, 2023)

Amendment No. 1 to Credit Agreement and Guaranty, dated March 23, 2023 by and among the Company, Hayfin Services LLP and the lenders party thereto (Filed With SEC on March 23, 2023)

Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc., as representative of the several underwriters named therein, dated as of December 7, 2022 (Filed With SEC on December 7, 2022)

Form of Warrant to Purchase Stock, in the form issued by the Company to various entities affiliated with Hayfin Services LLP, dated as of March 23, 2022 (Filed With SEC on March 24, 2022)

Credit Agreement and Guaranty, dated as of March 23, 2022, by and among the Company, Hayfin Services LLP and the lenders party thereto (Filed With SEC on March 24, 2022)

Security Agreement, dated as of March 23, 2022, by and among the Company, certain subsidiaries of the Company and Hayfin Services LLP (Filed With SEC on March 24, 2022)

Rights Agreement, dated as of December 20, 2021, by and between ADMA Biologics, Inc. and Continental Stock Transfer and Trust Company, as rights agent (Filed With SEC on December 21, 2021)

Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc., as representative of the several underwriters named therein, dated as of October 21, 2021 (Filed With SEC on October 21, 2021)

Second Amendment to Plasma Purchase Agreement, effective as of May 12, 2021, by and between ADMA BioManufacturing, LLC and Grifols Worldwide Operations LTD (Filed With SEC on May 12, 2021)

Warrant to Purchase Stock, dated December 8, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on March 25, 2021)

Rights Agreement, dated as of December 16, 2020, by and between ADMA Biologics, Inc. and Continental Stock Transfer and Trust Company, as rights agent (Filed With SEC on December 16, 2020)

Note, dated December 8, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on December 9, 2020)

Amendment No. 2 to Credit Agreement and Guaranty, dated December 8, 2020 (Filed With SEC on December 9, 2020)

Note, dated March 20, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on March 20, 2020)

Description of Capital Stock of ADMA Biologics, Inc (Filed With SEC on March 13, 2020)

Underwriting Agreement by and among the Company and the Underwriters dated as of February 6, 2020 (Filed With SEC on February 7, 2020)

Underwriting Agreement by and among the Company and the Underwriters dated as of May 16, 2019 (Filed With SEC on May 17, 2019)

Note, dated May 3, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on May 3, 2019)

Warrant to Purchase Stock, dated May 3, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on May 3, 2019)

Amendment No. 1 to Credit Agreement and Guaranty, dated as of May 3, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA... (Filed With SEC on May 3, 2019)

Note, dated February 11, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on February 12, 2019)

Warrant to Purchase Stock, dated February 11, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on February 12, 2019)

Security Agreement, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and Perceptive... (Filed With SEC on February 12, 2019)

Credit Agreement and Guaranty, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and... (Filed With SEC on February 12, 2019)

Fifth Amendment to Plasma Purchase Agreement, effective as of January 1, 2019, by and between ADMA Biologics, Inc. and Grifols Worldwide Operations Limited (Filed With SEC on January 2, 2019)

ADMA BIOLOGICS, INC. (125) | Business Finance (26)